The cryopreservation freezers market is worth USD 676 million in 2025 and is poised to reach USD 1,233.7 million by 2035, which shows a CAGR of 6.2%.
Market growth is being driven by the rising demand for advanced preservation solutions in biobanking, regenerative medicine, cell therapy, and pharmaceutical research. Cryopreservation freezers are essential for maintaining the viability of biological samples such as cells, tissues, blood components, stem cells, and genetic material at ultra-low temperatures.
The global expansion of biobanking networks and the increasing adoption of personalized medicine and advanced cell therapies are fueling the need for reliable, long-term storage solutions. Moreover, the pharmaceutical industry's growing reliance on biologics and temperature-sensitive vaccines is further accelerating demand for high-performance cryopreservation freezers.
Technological advancements are reshaping the market by enhancing performance, efficiency, and sustainability. Manufacturers are investing in ultra-low temperature (ULT) freezers with improved temperature uniformity, energy efficiency, and advanced data monitoring capabilities. The development of eco-friendly refrigerants and low-carbon cooling technologies is gaining momentum as manufacturers respond to regulatory pressures and corporate sustainability goals.
Additionally, the market is witnessing increased adoption of IoT-enabled freezers, enabling real-time temperature monitoring and predictive maintenance to ensure sample integrity. Demand for modular and scalable freezer systems is growing across biopharma companies, clinical research organizations, and academic institutions to support evolving storage needs driven by expanding pipelines of advanced biologics and cell-based therapies.
Government regulations are playing a critical role in shaping the market as global standards for biological sample preservation become more stringent. Regulatory agencies such as the FDA, EMA, and ICH mandate strict temperature control and validated storage conditions for biologics, cell therapies, and clinical trial materials. Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines require comprehensive temperature monitoring, data logging, and quality assurance for cryogenic storage.
Additionally, environmental regulations, such as the EU’s F-Gas Regulation and U.S. EPA SNAP program, are driving the shift toward low-GWP refrigerants and energy-efficient freezer technologies. Compliance with these evolving standards is pushing manufacturers to develop innovative and reliable cryopreservation solutions for a rapidly advancing life sciences sector.
Market Metrics
Metric | Value |
---|---|
Industry Size (2025E) | USD 676 million |
Industry Value (2035F) | USD 1,233.7 million |
CAGR (2025 to 2035) | 6.2% |
The market is segmented based on product, end user, and region. By product, the market is divided into tunnel freezer, IQF freezer, immersion freezer, and spiral freezer. Based on end user, the market is categorized into medical and healthcare settings, bio-pharma companies, blood banks, and research institutes. Regionally, the market is classified into North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, and the Middle East and Africa.
The tunnel freezer segment is projected to dominate the market, holding a 41.2% share in 2025. These freezers are widely adopted in biopharmaceutical and blood banking applications due to their ability to handle large batch volumes with high throughput. They offer continuous freezing with precise temperature control, ensuring rapid and uniform cryopreservation of sensitive biological materials.
Biopharma companies increasingly rely on tunnel freezers for freezing cell therapies, biologics, and vaccines, where maintaining cell viability and product stability is critical. Blood banks use tunnel freezers to rapidly process plasma and blood components while preserving biological integrity.
In addition, advancements in automation and energy efficiency are enhancing the appeal of tunnel freezers for large scale operations. IQF and immersion freezers are gaining adoption for specialized applications where individualized cryopreservation is required. Spiral freezers serve niche uses in facilities with limited space but requiring high performance.
As the global demand for regenerative medicine, advanced therapies, and biologics continues to expand, tunnel freezers are expected to retain their leadership in supporting efficient and reliable cryopreservation processes.
Product | Share (2025) |
---|---|
Tunnel Freezer | 41.2% |
The biopharma companies segment holds 37.5% market share in 2025 due to growing demand for cryopreservation freezers across regenerative medicine, advanced therapies, and biomanufacturing. Biopharmaceutical firms rely heavily on cryogenic freezers to preserve cell therapies, monoclonal antibodies, vaccines, and gene therapy products.
The ability to maintain ultra-low temperatures and ensure consistent freeze profiles is critical to safeguarding product potency and efficacy. Increasing R&D investments in cell and gene therapies, as well as personalized medicine, are further fueling demand for advanced cryopreservation solutions.
Biopharma companies also require scalable, GMP compliant freezer systems to support clinical trial material storage and commercial production. Medical and healthcare settings represent a strong secondary segment, where freezers are used for long term storage of tissue samples, stem cells, and reproductive cells.
Blood banks and research institutes contribute to overall market growth by adopting high performance freezers for clinical and scientific applications. With the biopharma sector continuing to drive innovation and investment in cell based and biologic therapies, demand for advanced cryopreservation freezers is expected to remain robust.
End User | Share (2025) |
---|---|
Biopharma Companies | 37.5% |
Challenges in cryopreservation freezers include high costs, regulatory barriers, and risks from power failures
Cryopreservation freezers remain amongst the more significant challenges and challenges, mostly impacting smaller research hospitals and health service providers because cryopreservation is expensive. Then there is tight regulatory standards related to how stored and moved biosamples; preservation at ultracold temperatures cannot be sustained reliably without continuous high-quality power delivery and sensitive support.
In many developing regions, low awareness of cryopreservation techniques limits the adoption rates. In addition, the potential for freezer failures and power outages jeopardizes sample integrity; therefore, it is imperative for institutions to invest in backup systems and advanced monitoring solutions to avoid potential losses.
Smart cryopreservation advances in automation, AI monitoring, and sustainability drive innovation in storage solutions
The automation of smart cryopreservation systems, along with advances in efficiency and reliability, open new doors to efficiency and reliability. Cloud-based temperature monitoring, predictive maintenance based on artificial intelligence, and robotic handling technology are helping laboratories reduce man-made mistakes and automate processes.
Sustainability is also becoming a top driver in the technology sector with firms trying to develop energy-efficient freezers as well as climate-friendly refrigerants that meet strict environmental standards. The advancing regenerative medicine, personalized therapy, and the rising demand for stem cell banking itself are becoming very important drivers in call for high-performance cryopreservation solutions.
Collaboration too is an important driver among biobanks, pharmaceutical companies, and research institutions; their collaboration fuels innovations in cryogenic storage and preservation techniques, which form the vistas of the future industry.
Market Outlook
United States cryopreservation freezers market is growing at a rapid rate with the development in technology in regenerative medicine and growth in activity in biobanking. Growing demand for chronic diseases to be preserved for long-term storage also drives demand for the market. The presence of leading biotechnology firms and significant research funding further expands the market.
Market Growth Factors
Market Forecast
Year | CAGR (2025 to 2035) |
---|---|
2025 to 2035 | 3.5% |
Market Outlook
Germany's cryopreservation freezers market is seeing growth due to its strong infrastructure in healthcare facilities and a tendency towards medical research. The strong commitment of Germany towards scientific progression and biotechnological development favors the adoption of advanced cryopreservation technologies.
Market Growth Factors
Market Forecast
Year | CAGR (2025 to 2035) |
---|---|
2025 to 2035 | 3.0% |
Market Outlook
Following the wave of healthcare investments and biobanking activities on the rise, the cryopreservation freezers market has witnessed a rapid growth in India. An increased focus on stem-cell research and regenerative medicine further entitles market growth.
Market Growth Factors
Market Forecast
Year | CAGR (2025 to 2035) |
---|---|
2025 to 2035 | 7.2% |
Market Outlook
The market for cryopreservation freezers in Japan rides on the pillar of advanced technological prowess and strong biomedical research in the country. Japan's aging population and the emphasis on improving healthcare innovations lead to the demand for cryopreservation solutions.
Market Growth Factors
Market Forecast
Year | CAGR (2025 to 2035) |
---|---|
2025 to 2035 | 5.3% |
Market Outlook
The market of cryopreservation freezers in Brazil invigorated by the ongoing development of healthcare infrastructure and biomedical research activities in the country need not any emphasis. Improvements in healthcare services and research capabilities continue now holding the power of expanding this market.
Market Growth Factors
Market Forecast
Year | CAGR (2025 to 2035) |
---|---|
2025 to 2035 | 6.0% |
Report Attributes | Details |
---|---|
Current Total Market Size (2025) | USD 676 million |
Projected Market Size (2035) | USD 1233.7 million |
CAGR (2025 to 2035) | 6.2% |
Base Year for Estimation | 2024 |
Historical Period | 2020 to 2024 |
Projections Period | 2025 to 2035 |
Market Analysis Parameter | Revenue in USD million |
By Product | Tunnel Freezer, IQF Freezer, Immersion Freezer, Spiral Freezer |
By End User | Medical and Healthcare settings, Bio-pharma companies, Blood Banks, Research Institutes |
Regions Covered | North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, Middle East and Africa |
Countries Covered | United States, Japan, Germany, India, United Kingdom, France, Italy, Brazil, Canada, South Korea, Australia, Spain, Netherlands, Saudi Arabia, Switzerland |
Key Players | ACMAS Technologies Pvt. Ltd, Air Water Inc., ARCTIKO AS, Aucma Co. Ltd, Avantor Inc., BioLife Solutions, Inc., Brooks Automation Inc., Chart Industries Inc., ZHONGKE MEILING CRYOGENICS CO. LTD., Froilabo, Haier Biomedical, Hamilton Thorne Ltd., Helmer Scientific Inc., Panasonic Holdings Corp., PHC Holdings Corp., Scientific Research Instruments Co Pvt Ltd, Thermo Fisher Scientific Inc., Wuxi Guanya Refrigeration Technology Co. Ltd., Scimed Asia Pte Ltd., Stericox India Pvt. Ltd. |
Additional Attributes | Rising demand for cost-effective dairy alternatives, growing infant nutrition sector, expanding bakery industry |
Customization and Pricing | Available upon request |
Table 03: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Region
Table 01: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Product
Table 02: Global Market Volume (Units) Analysis and Forecast 2017 to 2033, By Product
Table 03: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By End User
Table 04: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 05: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Product
Table 06: North America Market Volume (Units) Analysis and Forecast 2017 to 2033, By Product
Table 07: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By End User
Table 08: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 09: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Product
Table 10: Latin America Market Volume (Units) Analysis and Forecast 2017 to 2033, By Product
Table 11: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By End User
Table 12: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 13: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Product
Table 14: Europe Market Volume (Units) Analysis and Forecast 2017 to 2033, By Product
Table 15: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By End User
Table 16: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 17: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Product
Table 18: South Asia Market Volume (Units) Analysis and Forecast 2017 to 2033, By Product
Table 19: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By End User
Table 20: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 21: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Product
Table 22: East Asia Market Volume (Units) Analysis and Forecast 2017 to 2033, By Product
Table 23: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By End User
Table 24: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 25: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Product
Table 26: Oceania Market Volume (Units) Analysis and Forecast 2017 to 2033, By Product
Table 27: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By End User
Table 28: Middle East and Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 29: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Product
Table 30: Middle East and Africa Market Volume (Units) Analysis and Forecast 2017 to 2033, By Product
Table 31: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By End User
Figure 01: Global Market Volume (Units), 2017 to 2022
Figure 02: Global Market Volume (Units) & Y-O-Y Growth (%) Analysis, 2023 to 2033
Figure 03: Global Market, Pricing Analysis Per Unit (US$), In 2022
Figure 04: Global Market, Pricing Forecast Per Unit (US$), In 2033
Figure 05: Global Market Value (US$ Million) Analysis, 2017 to 2022
Figure 06: Global Market Forecast & Y-O-Y Growth, 2023 to 2033
Figure 07: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022–2033
Figure 08: Global Market Value Share (%) Analysis 2023 and 2033, By Product
Figure 09: Global Market Y-O-Y Growth (%) Analysis 2022 to 2033, By Product
Figure 10: Global Market Attractiveness Analysis 2023 to 2033, By Product
Figure 11: Global Market Value Share (%) Analysis 2023 and 2033, By End User
Figure 12: Global Market Y-O-Y Growth (%) Analysis 2022 to 2033, By End User
Figure 13: Global Market Attractiveness Analysis 2023 to 2033, By End User
Figure 14: Global Market Value Share (%) Analysis 2023 and 2033, By Region
Figure 15: Global Market Y-O-Y Growth (%) Analysis 2022 to 2033, By Region
Figure 16: Global Market Attractiveness Analysis 2023 to 2033, By Region
Figure 17: North America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 18: North America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 19: North America Market Value Share, By Product (2023 E)
Figure 20: North America Market Value Share, By End User(2023 E)
Figure 21: North America Market Value Share, By Country (2023 E)
Figure 22: North America Market Attractiveness Analysis By Product, 2023 to 2033
Figure 23: North America Market Attractiveness Analysis By End User, 2023 to 2033
Figure 24: North America Market Attractiveness Analysis By Country, 2023 to 2033
Figure 25: U.S. Market Value Proportion Analysis, 2022
Figure 26: Global Vs. U.S. Growth Comparison, 2022 to 2033
Figure 27: U.S. Market Share Analysis (%) By Product, 2022 & 2033
Figure 28: U.S. Market Share Analysis (%) By End User, 2022 & 2033
Figure 29: Canada Market Value Proportion Analysis, 2022
Figure 30: Global Vs. Canada. Growth Comparison, 2022 to 2033
Figure 31: Canada Market Share Analysis (%) By Product, 2022 & 2033
Figure 32: Canada Market Share Analysis (%) By End User, 2022 & 2033
Figure 33: Latin America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 34: Latin America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 35: Latin America Market Value Share, By Product (2023 E)
Figure 36: Latin America Market Value Share, By End User(2023 E)
Figure 37: Latin America Market Value Share, By Country (2023 E)
Figure 38: Latin America Market Attractiveness Analysis By Product, 2023 to 2033
Figure 39: Latin America Market Attractiveness Analysis By End User, 2023 to 2033
Figure 40: Latin America Market Attractiveness Analysis By Country, 2023 to 2033
Figure 41: Mexico Market Value Proportion Analysis, 2022
Figure 42: Global Vs Mexico Growth Comparison, 2022 to 2033
Figure 43: Mexico Market Share Analysis (%) By Product, 2022 & 2033
Figure 44: Mexico Market Share Analysis (%) By End User, 2022 & 2033
Figure 45: Brazil Market Value Proportion Analysis, 2022
Figure 46: Global Vs. Brazil. Growth Comparison, 2022 to 2033
Figure 47: Brazil Market Share Analysis (%) By Product, 2022 & 2033
Figure 48: Brazil Market Share Analysis (%) By End User, 2022 & 2033
Figure 49: Argentina Market Value Proportion Analysis, 2022
Figure 50: Global Vs Argentina Growth Comparison, 2022 to 2033
Figure 51: Argentina Market Share Analysis (%) By Product, 2022 & 2033
Figure 52: Argentina Market Share Analysis (%) By End User, 2022 & 2033
Figure 53: Europe Market Value (US$ Million) Analysis, 2017 to 2022
Figure 54: Europe Market Value (US$ Million) Forecast, 2023 to 2033
Figure 55: Europe Market Value Share, By Product (2023 E)
Figure 56: Europe Market Value Share, By End User(2023 E)
Figure 57: Europe Market Value Share, By Country (2023 E)
Figure 58: Europe Market Attractiveness Analysis By Product, 2023 to 2033
Figure 59: Europe Market Attractiveness Analysis By End User, 2023 to 2033
Figure 60: Europe Market Attractiveness Analysis By Country, 2023 to 2033
Figure 61: UK Market Value Proportion Analysis, 2022
Figure 62: Global Vs. UK Growth Comparison, 2022 to 2033
Figure 63: UK Market Share Analysis (%) By Product, 2022 & 2033
Figure 64: UK Market Share Analysis (%) By End User, 2022 & 2033
Figure 65: Germany Market Value Proportion Analysis, 2022
Figure 66: Global Vs. Germany Growth Comparison, 2022 to 2033
Figure 67: Germany Market Share Analysis (%) By Product, 2022 & 2033
Figure 68: Germany Market Share Analysis (%) By End User, 2022 & 2033
Figure 69: Italy Market Value Proportion Analysis, 2022
Figure 70: Global Vs. Italy Growth Comparison, 2022 to 2033
Figure 71: Italy Market Share Analysis (%) By Product, 2022 & 2033
Figure 72: Italy Market Share Analysis (%) By End User, 2022 & 2033
Figure 73: France Market Value Proportion Analysis, 2022
Figure 74: Global Vs France Growth Comparison, 2022 to 2033
Figure 75: France Market Share Analysis (%) By Product, 2022 & 2033
Figure 76: France Market Share Analysis (%) By End User, 2022 & 2033
Figure 77: Spain Market Value Proportion Analysis, 2022
Figure 78: Global Vs Spain Growth Comparison, 2022 to 2033
Figure 79: Spain Market Share Analysis (%) By Product, 2022 & 2033
Figure 80: Spain Market Share Analysis (%) By End User, 2022 & 2033
Figure 81: Russia Market Value Proportion Analysis, 2022
Figure 82: Global Vs Russia Growth Comparison, 2022 to 2033
Figure 83: Russia Market Share Analysis (%) By Product, 2022 & 2033
Figure 84: Russia Market Share Analysis (%) By End User, 2022 & 2033
Figure 85: Benelux Market Value Proportion Analysis, 2022
Figure 86: Global Vs Benelux Growth Comparison, 2022 to 2033
Figure 87: Benelux Market Share Analysis (%) By Product, 2022 & 2033
Figure 88: Benelux Market Share Analysis (%) By End User, 2022 & 2033
Figure 89: East Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 90: East Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 91: East Asia Market Value Share, By Product (2023 E)
Figure 92: East Asia Market Value Share, By End User(2023 E)
Figure 93: East Asia Market Value Share, By Country (2023 E)
Figure 94: East Asia Market Attractiveness Analysis By Product, 2023 to 2033
Figure 95: East Asia Market Attractiveness Analysis By End User, 2023 to 2033
Figure 96: East Asia Market Attractiveness Analysis By Country, 2023 to 2033
Figure 97: China Market Value Proportion Analysis, 2022
Figure 98: Global Vs. China Growth Comparison, 2022 to 2033
Figure 99: China Market Share Analysis (%) By Product, 2022 & 2033
Figure 100: China Market Share Analysis (%) By End User, 2022 & 2033
Figure 101: Japan Market Value Proportion Analysis, 2022
Figure 102: Global Vs. Japan Growth Comparison, 2022 to 2033
Figure 103: Japan Market Share Analysis (%) By Product, 2022 & 2033
Figure 104: Japan Market Share Analysis (%) By End User, 2022 & 2033
Figure 105: South Korea Market Value Proportion Analysis, 2022
Figure 106: Global Vs South Korea Growth Comparison, 2022 to 2033
Figure 107: South Korea Market Share Analysis (%) By Product, 2022 & 2033
Figure 108: South Korea Market Share Analysis (%) By End User, 2022 & 2033
Figure 109: South Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 110: South Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 111: South Asia Market Value Share, By Product (2023 E)
Figure 112: South Asia Market Value Share, By End User(2023 E)
Figure 113: South Asia Market Value Share, By Country (2023 E)
Figure 114: South Asia Market Attractiveness Analysis By Product, 2023 to 2033
Figure 115: South Asia Market Attractiveness Analysis By End User, 2023 to 2033
Figure 116: South Asia Market Attractiveness Analysis By Country, 2023 to 2033
Figure 117: India Market Value Proportion Analysis, 2022
Figure 118: Global Vs. India Growth Comparison, 2022 to 2033
Figure 119: India Market Share Analysis (%) By Product, 2022 & 2033
Figure 120: India Market Share Analysis (%) By End User, 2022 & 2033
Figure 121: Indonesia Market Value Proportion Analysis, 2022
Figure 122: Global Vs. Indonesia Growth Comparison, 2022 to 2033
Figure 123: Indonesia Market Share Analysis (%) By Product, 2022 & 2033
Figure 124: Indonesia Market Share Analysis (%) By End User, 2022 & 2033
Figure 125: Malaysia Market Value Proportion Analysis, 2022
Figure 126: Global Vs. Malaysia Growth Comparison, 2022 to 2033
Figure 127: Malaysia Market Share Analysis (%) By Product, 2022 & 2033
Figure 128: Malaysia Market Share Analysis (%) By End User, 2022 & 2033
Figure 129: Thailand Market Value Proportion Analysis, 2022
Figure 130: Global Vs. Thailand Growth Comparison, 2022 to 2033
Figure 131: Thailand Market Share Analysis (%) By Product, 2022 & 2033
Figure 132: Thailand Market Share Analysis (%) By End User, 2022 & 2033
Figure 133: Oceania Market Value (US$ Million) Analysis, 2017 to 2022
Figure 134: Oceania Market Value (US$ Million) Forecast, 2023 to 2033
Figure 135: Oceania Market Value Share, By Product (2023 E)
Figure 136: Oceania Market Value Share, By End User(2023 E)
Figure 137: Oceania Market Value Share, By Country (2023 E)
Figure 138: Oceania Market Attractiveness Analysis By Product, 2023 to 2033
Figure 139: Oceania Market Attractiveness Analysis By End User, 2023 to 2033
Figure 140: Oceania Market Attractiveness Analysis By Country, 2023 to 2033
Figure 141: Australia Market Value Proportion Analysis, 2022
Figure 142: Global Vs. Australia Growth Comparison, 2022 to 2033
Figure 143: Australia Market Share Analysis (%) By Product, 2022 & 2033
Figure 144: Australia Market Share Analysis (%) By End User, 2022 & 2033
Figure 145: New Zealand Market Value Proportion Analysis, 2022
Figure 146: Global Vs New Zealand Growth Comparison, 2022 to 2033
Figure 147: New Zealand Market Share Analysis (%) By Product, 2022 & 2033
Figure 148: New Zealand Market Share Analysis (%) By End User, 2022 & 2033
Figure 149: Middle East & Africa Market Value (US$ Million) Analysis, 2017 to 2022
Figure 150: Middle East & Africa Market Value (US$ Million) Forecast, 2023 to 2033
Figure 151: Middle East & Africa Market Value Share, By Product (2023 E)
Figure 152: Middle East & Africa Market Value Share, By End User(2023 E)
Figure 153: Middle East & Africa Market Value Share, By Country (2023 E)
Figure 154: Middle East & Africa Market Attractiveness Analysis By Product, 2023 to 2033
Figure 155: Middle East & Africa Market Attractiveness Analysis By End User, 2023 to 2033
Figure 156: Middle East & Africa Market Attractiveness Analysis By Country, 2023 to 2033
Figure 157: GCC Countries Market Value Proportion Analysis, 2022
Figure 158: Global Vs GCC Countries Growth Comparison, 2022 to 2033
Figure 159: GCC Countries Market Share Analysis (%) By Product, 2022 & 2033
Figure 160: GCC Countries Market Share Analysis (%) By End User, 2022 & 2033
Figure 161: Türkiye Market Value Proportion Analysis, 2022
Figure 162: Global Vs. Türkiye Growth Comparison, 2022 to 2033
Figure 163: Türkiye Market Share Analysis (%) By Product, 2022 & 2033
Figure 164: Türkiye Market Share Analysis (%) By End User, 2022 & 2033
Figure 165: South Africa Market Value Proportion Analysis, 2022
Figure 166: Global Vs. South Africa Growth Comparison, 2022 to 2033
Figure 167: South Africa Market Share Analysis (%) By Product, 2022 & 2033
Figure 168: South Africa Market Share Analysis (%) By End User, 2022 & 2033
Figure 169: Northern Africa Market Value Proportion Analysis, 2022
Figure 170: Global Vs Northern Africa Growth Comparison, 2022 to 2033
Figure 171: Northern Africa Market Share Analysis (%) By Product, 2022 & 2033
Figure 172: Northern Africa Market Share Analysis (%) By End User, 2022 & 2033
The global market is forecasted to reach USD 1,233.7 million by 2035, growing from USD 676 million in 2025, at a CAGR of 6.2%.
The tunnel freezer segment dominate with a 41.2% market share in 2025, driven by demand for large-volume and high-throughput applications.
Biopharma companies hold the leading 37.5% market share in 2025, fueled by growth in regenerative medicine, cell therapies, and biomanufacturing.
Key drivers include expanding biobanking networks, rising demand for personalized medicine, advancements in cell and gene therapies, and stricter regulatory standards.
Top players include Thermo Fisher Scientific, Sartorius AG, BioLife Solutions Inc., Panasonic Healthcare, and Custom Biogenic Systems.
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.